Zoster mRNA Vaccine (Abogenbio/Walvax Biotech)

冻干带状疱疹病毒mRNA疫苗（艾博生物/沃森生物）

Report date: 2025/12/11 14:45:36

Base Information

Drug NameZoster mRNA Vaccine (Abogenbio/Walvax Biotech)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAbon Biopharm (Hangzhou) Co LtdWalvax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Watson Innovation Biotechnology Co., Ltd.
Inactive CompaniesAbon Biopharm (Hangzhou) Co LtdWalvax Biotechnology Co Ltd
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A